SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+29.39%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.42B
AUM Growth
+$1.42B
(+22%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
112
New
24
Increased
30
Reduced
36
Closed
15
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$62.3M |
| 2 |
Maravai LifeSciences
MRVI
|
$27.5M |
| 3 |
Replimune Group
REPL
|
$25.5M |
| 4 |
Tandem Diabetes Care
TNDM
|
$23.8M |
| 5 |
Certara
CERT
|
$20.4M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$51M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
$18.7M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
$18.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$17.7M |
| 5 |
Assembly Biosciences
ASMB
|
$15.1M |
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Industrials | 1.99% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Idexx Laboratories
IDXX
$50.7B
| $23.7M | 1.67% |
47,399
+6,200
| +15% | +$3.1M |
|
27
Arcus Biosciences
RCUS
$1.24B
| $22.4M | 1.58% |
861,160
-61,640
| -7% | -$1.6M |
|
|
28
Certara
CERT
$1.69B
| $20.4M | 1.44% |
+605,900
| New | +$20.4M |
|
29
Rocket Pharmaceuticals
RCKT
$358M
| $20.1M | 1.42% |
+367,385
| New | +$20.1M |
|
30
Zimmer Biomet
ZBH
$20.8B
| $18.6M | 1.31% |
+121,000
| New | +$18.6M |
|
31
American Well
AMWL
$112M
| $18.3M | 1.29% |
724,120
+118,970
| +20% | +$3.01M |
|
|
PRAH
32
DELISTED
PRA Health Sciences, Inc.
PRAH
| $17.2M | 1.21% |
136,770
+4,150
| +3% | +$521K |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.2M | 1.14% |
+73,638
| New | +$16.2M |
|
34
DexCom
DXCM
$30.9B
| $15.7M | 1.11% |
42,463
-5,950
| -12% | -$2.2M |
|
35
Revolution Medicines
RVMD
$7.43B
| $15.4M | 1.09% |
389,006
-244,084
| -39% | -$9.66M |
|
36
Centene
CNC
$14.8B
| $15.4M | 1.09% |
256,515
-133,575
| -34% | -$8.02M |
|
|
BPMC
37
DELISTED
Blueprint Medicines
BPMC
| $15.3M | 1.08% |
136,500
-158,233
| -54% | -$17.7M |
|
|
OSH
38
DELISTED
Oak Street Health, Inc.
OSH
| $15.3M | 1.08% |
+250,000
| New | +$15.3M |
|
39
Sarepta Therapeutics
SRPT
$1.98B
| $14.8M | 1.04% |
86,624
-5,650
| -6% | -$963K |
|
40
ResMed
RMD
$39.4B
| $14.1M | 0.99% |
66,305
-6,000
| -8% | -$1.28M |
|
41
Alnylam Pharmaceuticals
ALNY
$58.6B
| $14.1M | 0.99% |
+108,346
| New | +$14.1M |
|
|
ALXN
42
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $13.7M | 0.97% |
87,976
+36,700
| +72% | +$5.73M |
|
43
Moderna
MRNA
$9.36B
| $13.2M | 0.93% |
126,306
-9,650
| -7% | -$1.01M |
|
|
FRLN
44
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $12M | 0.85% |
657,494
-185,357
| -22% | -$3.38M |
|
45
Johnson & Johnson
JNJ
$429B
| $11.7M | 0.83% |
74,500
| – | – |
|
46
Hologic
HOLX
$14.7B
| $11.5M | 0.81% |
158,300
+5,700
| +4% | +$415K |
|
47
Insulet
PODD
$24.2B
| $10.9M | 0.77% |
42,654
-2,000
| -4% | -$511K |
|
|
SGTX
48
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $10.8M | 0.76% |
+225,000
| New | +$10.8M |
|
49
TG Therapeutics
TGTX
$5.03B
| $10.7M | 0.76% |
+206,549
| New | +$10.7M |
|
50
AbbVie
ABBV
$374B
| $10.2M | 0.72% |
95,250
+9,000
| +10% | +$964K |
|